Sarah R. Vaiselbuh
- Hematology top 10%
-
- MicroRNA in disease regulation 5
-
- Parvovirus B19 Infection Studies 3
-
- Histiocytic Disorders and Treatments 4
-
- Extracellular vesicles in disease 6
- RNA Interference and Gene Delivery 2
-
- Childhood Cancer Survivors' Quality of Life 2
-
- Adolescent and Pediatric Healthcare 2
-
- Diversity and Career in Medicine 2
- Co-authors
- Shabirul HaqueCarl E. AllenJames A. WhitlockOussama AblaYenan T. BrycesonJeffrey M. LiptonMorris EdelmanJohnson M. Liu
- Journals
- Pediatric Blood & Cancer (6 papers)Journal of Clinical Oncology (2 papers)Tissue Engineering Part C Methods (1 paper)
- Partner nations
- United StatesCanadaSweden
In The Last Decade
Sarah R. Vaiselbuh
18 papers receiving 336 citations
Peers
Comparison fields: 5 of 56
- Hematology 79
- Cancer Research 65
- Infectious Diseases 79
- Immunology 82
- Physiology 81
Countries citing papers authored by Sarah R. Vaiselbuh
This map shows the geographic impact of Sarah R. Vaiselbuh's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sarah R. Vaiselbuh with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sarah R. Vaiselbuh more than expected).
Fields of papers citing papers by Sarah R. Vaiselbuh
This network shows the impact of papers produced by Sarah R. Vaiselbuh. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sarah R. Vaiselbuh. The network helps show where Sarah R. Vaiselbuh may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Sarah R. Vaiselbuh, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2021 | 9 | |
| 2 | 2021 | 50 | |
| 3 | 2020 | 8 | |
| 4 | 2020 | 1 | |
| 5 | 2020 | 31 | |
| 6 | 2018 | 10 | |
| 7 | 2016 | 5 | |
| 8 | 2016 | 6 | |
| 9 | 2016 | 0 | |
| 10 | 2016 | 6 | |
| 11 | 2016 | 15 | |
| 12 | 2016 | 18 | |
| 13 | 2016 | 15 | |
| 14 | 2016 | 37 | |
| 15 | 2015 | 6 | |
| 16 | 2014 | 65 | |
| 17 | 2014 | 11 | |
| 18 | 2011 | 12 | |
| 19 | 2010 | 34 |
About Sarah R. Vaiselbuh
Sarah R. Vaiselbuh is a scholar working on Cancer Research, Speech and Hearing and Gender Studies, having authored 19 papers that have together received 339 indexed citations. Recurring topics across this work include Extracellular vesicles in disease (6 papers), MicroRNA in disease regulation (5 papers), Histiocytic Disorders and Treatments (4 papers), Parvovirus B19 Infection Studies (3 papers), Childhood Cancer Survivors' Quality of Life (2 papers), RNA Interference and Gene Delivery (2 papers), Adolescent and Pediatric Healthcare (2 papers) and Diversity and Career in Medicine (2 papers). The work is most often cited by research in Hematology (79 citations), Cancer Research (65 citations) and Infectious Diseases (79 citations). Sarah R. Vaiselbuh has collaborated with scholars based in United States, Canada and Sweden. Frequent co-authors include Shabirul Haque, Carl E. Allen, James A. Whitlock, Oussama Abla, Yenan T. Bryceson, Jeffrey M. Lipton, Morris Edelman, Johnson M. Liu, Joanna Pierro and Michael B. Jordan. Their work appears in journals such as Pediatric Blood & Cancer, Journal of Clinical Oncology, Tissue Engineering Part C Methods, Blood and Cancers.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.